Just because a company invests does not mean it has invented anything novel,” Tahir Amin and Rohit Malpani write in this ...

CEO of BigHat Biosciences, which designs antibody therapies using machine-learning, on how AI can, and cannot, help in drug ...

President Trump had another medical exam on Tuesday, putting his health under renewed public scrutiny after he has worked to ...

People in the food world didn’t know what to expect when the Trump administration appointed a little-known Florida attorney ...

On Sunday, the World Health Organization (WHO) declared an Ebola outbreak in the Democratic Republic of the Congo and Uganda to be a public health emergency. This outbreak is deadly, with hundreds of ...

Eli Lilly is acquiring three small vaccine developers, expanding its work in infectious diseases and giving the field a boost ...

Bob covers the money in health care, focusing on health insurance and hospitals. His stories delve into Medicare Advantage, opaque prescription drug benefits, and how much executives actually make. He ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics ...

John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07. WASHINGTON — A group of Senate ...

The Trump administration disclosed plans to reduce state directed payments even more, setting up a probable showdown with ...

My patients are replacing olive oil with beef tallow, even if they don't tell me during cardiac rehab,” writes a clinical ...

President Trump's cuts to foreign aid probably hampered the detection of the Ebola outbreak and the response to it.